Abstract
The maintenance and assembly of chromatin is critical for the health of all cells. Cells, whether dividing or quiescent, that propagate damaged DNA or maintain chromosomes that are not properly assembled and/or packaged will ultimately succumb to genomic instability and cell death. Chromatin, the building block of the chromosome, is composed of repeated units of 147 basepairs of DNA wrapped around two copies of each of the four core histones, H2A, H2B, H3 and H4. Histones within chromatin serve as templates for a host of posttranslational modifications that facilitate virtually all events that require chromatin or chromosomes. Many studies have focused on the molecular mechanisms mediating and regulating the assembly process. These studies have utilized model systems ranging from yeast to humans. The regulatory processes are tightly linked to the cell cycle and require precise interactions between kinase cascades and the ubiquitintargeting pathway. It appears likely that not only are the series of factors required to assemble chromatin conserved across evolutionary boundaries, but so are the regulatory mechanisms that control these processes. The implications of these findings to research make it clear that lower eukaryotic model systems provide a powerful opportunity to learn valuable lessons about complicated higher eukaryotic molecular pathways. The lessons learned from yeast studies will provide valuable insight into understanding the disease processes that occur in humans as a result of impaired chromatin assembly.
Keywords: chromatin assembly, caf-I, anaphase promoting complex, mitosis, evolutionary conservation
Current Genomics
Title: Chromatin Assembly from Yeast to Man: Conserved Factors and Conserved Molecular Mechanisms
Volume: 6 Issue: 4
Author(s): Troy A.A. Harkness
Affiliation:
Keywords: chromatin assembly, caf-I, anaphase promoting complex, mitosis, evolutionary conservation
Abstract: The maintenance and assembly of chromatin is critical for the health of all cells. Cells, whether dividing or quiescent, that propagate damaged DNA or maintain chromosomes that are not properly assembled and/or packaged will ultimately succumb to genomic instability and cell death. Chromatin, the building block of the chromosome, is composed of repeated units of 147 basepairs of DNA wrapped around two copies of each of the four core histones, H2A, H2B, H3 and H4. Histones within chromatin serve as templates for a host of posttranslational modifications that facilitate virtually all events that require chromatin or chromosomes. Many studies have focused on the molecular mechanisms mediating and regulating the assembly process. These studies have utilized model systems ranging from yeast to humans. The regulatory processes are tightly linked to the cell cycle and require precise interactions between kinase cascades and the ubiquitintargeting pathway. It appears likely that not only are the series of factors required to assemble chromatin conserved across evolutionary boundaries, but so are the regulatory mechanisms that control these processes. The implications of these findings to research make it clear that lower eukaryotic model systems provide a powerful opportunity to learn valuable lessons about complicated higher eukaryotic molecular pathways. The lessons learned from yeast studies will provide valuable insight into understanding the disease processes that occur in humans as a result of impaired chromatin assembly.
Export Options
About this article
Cite this article as:
Harkness A.A. Troy, Chromatin Assembly from Yeast to Man: Conserved Factors and Conserved Molecular Mechanisms, Current Genomics 2005; 6 (4) . https://dx.doi.org/10.2174/1389202054395937
DOI https://dx.doi.org/10.2174/1389202054395937 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
Current Drug Targets Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets Optimising the Azeotropic Drying of 18F-Fluorine Wayto Improve the 18F-Fluorocholine Radiochemical Yield
Current Radiopharmaceuticals Modulation of the Ceramide Level, A Novel Therapeutic Concept
Current Drug Targets Amaranth: A Pseudo-Cereal with Nutraceutical Properties
Current Nutrition & Food Science Multidrug Transporters as Drug Targets
Current Drug Targets CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Chemopreventive Properties of Peptide Lunasin: A Review
Protein & Peptide Letters From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol
Anti-Cancer Agents in Medicinal Chemistry Applications of Nucleic Acid Drugs for Organ Transplantation
Current Topics in Medicinal Chemistry Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management
Current Vascular Pharmacology Recent Advancements for the Management of Pancreatic Cancer: Current Insights
Current Cancer Therapy Reviews Development of Novel Therapeutic Strategies for Lung Cancer: Targeting the Cholinergic System
Current Medicinal Chemistry An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini- Review
Endocrine, Metabolic & Immune Disorders - Drug Targets The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
Current Genomics Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
Current Pharmaceutical Design CYP24A1 as a Potential Target for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Pathogenesis of Susceptibility to Acute Kidney Injury in the Elderly
Current Aging Science Human Platelet Acetylcholinesterase Inhibition by Cyclophosphamide: A Combined Experimental and Computational Approach
CNS & Neurological Disorders - Drug Targets Antineovascular Agents in the Treatment of Eye Diseases
Current Pharmaceutical Design